Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2018

Feb 13, 2018

29828_dirs_2018-02-13_78c3a4a3-869f-42c9-80f9-9cd5fed2c78f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-02-09

Reporting Person: WILSON GAYLE E (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-09 Common Stock M 60000 $26.615 Acquired 182258 Direct
2018-02-09 Common Stock S 60000 $77.918 Disposed 122258 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-09 Non-qualified Stock Option (Right to Buy) $26.615 M 60000 Disposed 2018-05-08 Common Stock (60000) Direct

Footnotes

F1: Sale prices reported for the transactions reported here range from $77.88 to $78.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F2: Options vest 100% on the first anniversary date of the grant.